A randomized controlled trial of Sweet Talk, a text-messaging system to support young people with diabetes
A randomized controlled trial of Sweet Talk, a text-messaging system to support young people with diabetes
复制标题
DOI：
10.1111/j.1464-5491.2006.01989.x
复制
发表时间：
2006-12-01
影响因子：
3.5
通讯作者：
Greene, S. A.
中科院分区：
文献类型：
--
作者：
Franklin, V. L.;Waller, A.;Greene, S. A.
目的评估甜言蜜语，短信支持系统，旨在提高自我效能，促进摄取强化胰岛素治疗，提高血糖控制的儿科患者与I型diabetes.Methods一百二十六例患者符合资格标准; 1型糖尿病> 1年，常规胰岛素治疗，年龄8-18岁。92例患者随机接受常规胰岛素治疗（n = 28）、常规治疗+甜言蜜语（n = 33）或强化胰岛素治疗+甜言蜜语（n = 31）。通过每天发送来自Sweet Talk软件系统的短信来加强门诊访视时的目标设定，该短信包含针对患者年龄、性别和胰岛素治疗方案定制的个性化目标特定提示和消息。（10.3 +/- 1.7 vs. 10.1 +/- 1.7%），但随机接受强化治疗和甜言蜜语的患者有所改善（9.2 +/-2.2%，95% CI-1.9，-0.5，P < 0.001）。甜言蜜语与糖尿病自我效能的改善有关（常规治疗56.0 +/- 13.7，常规治疗加甜言蜜语62.1 +/- 6.6，95% CI +2.6，+7.5，P = 0.003）和自我报告的依从性（常规治疗70.4 ± 20.0，常规治疗加甜言蜜语77.2 ± 16.1，95% CI +0.4，+17.4，P = 0.042）。接受调查时，82%的患者认为，甜言蜜语改善了他们的糖尿病自我管理和90%的人希望继续接收messages.Conclusions甜言蜜语与提高自我效能和坚持;从事一个经典的难以达到的年轻人群体。虽然单独的甜言蜜语并不能改善血糖控制，但它可能在支持强化胰岛素治疗的引入方面发挥了作用。有计划、有针对性的短信提供了一种支持糖尿病青少年的创新手段，可适用于其他保健环境和慢性病。
Aims To assess Sweet Talk, a text-messaging support system designed to enhance self-efficacy, facilitate uptake of intensive insulin therapy and improve glycaemic control in paediatric patients with Type I diabetes.Methods One hundred and twenty-six patients fulfilled the eligibility criteria; Type 1 diabetes for > 1 year, on conventional insulin therapy, aged 8-18 years. Ninety-two patients were randomized to conventional insulin therapy (n = 28), conventional therapy and Sweet Talk (n = 33) or intensive insulin therapy and Sweet Talk (n = 31). Goal-setting at clinic visits was reinforced by daily text-messages from the Sweet Talk software system, containing personalized goal-specific prompts and messages tailored to patients' age, sex and insulin regimen.Results HbA(1c) did not change in patients on conventional therapy without or with Sweet Talk (10.3 +/- 1.7 vs. 10.1 +/- 1.7%), but improved in patients randomized to intensive therapy and Sweet Talk (9.2 +/- 2.2%, 95% CI -1.9, -0.5, P < 0.001). Sweet Talk was associated with improvement in diabetes self-efficacy (conventional therapy 56.0 +/- 13.7, conventional therapy plus Sweet Talk 62.1 +/- 6.6, 95% CI +2.6, +7.5, P = 0.003) and self-reported adherence (conventional therapy 70.4 +/- 20.0, conventional therapy plus Sweet Talk 77.2 +/- 16.1, 95% CI +0.4, +17.4, P = 0.042). When surveyed, 82% of patients felt that Sweet Talk had improved their diabetes self-management and 90% wanted to continue receiving messages.Conclusions Sweet Talk was associated with improved self-efficacy and adherence; engaging a classically difficult to reach group of young people. While Sweet Talk alone did not improve glycaemic control, it may have had a role in supporting the introduction of intensive insulin therapy. Scheduled, tailored text messaging offers an innovative means of supporting adolescents with diabetes and could be adapted for other health-care settings and chronic diseases.